Therapeutic targets for vaccination in polyomavirus-driven Merkel cell carcinoma
- PMID: 35560970
- DOI: 10.1111/dth.15580
Therapeutic targets for vaccination in polyomavirus-driven Merkel cell carcinoma
Comment in
-
Response to comment on "Merkel cell carcinoma: An updated review of pathogenesis, diagnosis, and treatment options".Dermatol Ther. 2022 Jul;35(7):e15581. doi: 10.1111/dth.15581. Epub 2022 May 26. Dermatol Ther. 2022. PMID: 35560755 No abstract available.
Comment on
-
Merkel cell carcinoma: An updated review of pathogenesis, diagnosis, and treatment options.Dermatol Ther. 2022 Mar;35(3):e15292. doi: 10.1111/dth.15292. Epub 2022 Jan 5. Dermatol Ther. 2022. PMID: 34967084 Review.
References
REFERENCES
-
- Hernandez LE, Mohsin N, Yaghi M, Frech FS, Dreyfuss I, Nouri K. Merkel cell carcinoma: an updated review of pathogenesis, diagnosis, and treatment options. Dermatol Ther. 2021;29:e15292.
-
- Tabachnick-Cherny S, Pulliam T, Church C, Koelle DM, Nghiem P. Polyomavirus-driven Merkel cell carcinoma: prospects for therapeutic vaccine development. Mol Carcinog. 2020;59(7):807-821.
-
- Gehrcken L, Sauerer T, Schaft N, Dörrie J. T-cell responses in Merkel cell carcinoma: implications for improved immune checkpoint blockade and other therapeutic options. Int J Mol Sci. 2021;22(16):8679.
-
- Longino NV, Yang J, Iyer JG, et al. Human CD4+ T cells specific for Merkel cell polyomavirus localize to Merkel cell carcinomas and target a required oncogenic domain. Cancer Immunol Res. 2019;7(10):1727-1739.
-
- Jing L, Ott M, Church CD, et al. Prevalent and diverse intratumoral oncoprotein-specific CD8+ T cells within polyomavirus-driven Merkel cell carcinomas. Cancer Immunol Res. 2020;8(5):648-659.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
